Brewin Dolphin LTD Regeneron Pharmaceuticals, Inc. Transaction History

Brewin Dolphin LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2023	BUY	$574.03 - $680.96 $5,740 - $6,809	10 Added 3.08%	335 $203 Million
Q2 2021 Nov 09, 2023	BUY	$472.8 - $558.54 $141,840 - $167,562	300 Added 1200.0%	325 $182 Million
Q1 2021 Nov 09, 2023	SELL	$446.73 - $548.2 $19,209 - $23,572	-43 Reduced 63.24%	25 $11.8 Million
Q4 2020 Nov 09, 2023	BUY	$478.3 - $607.98 $20,566 - $26,143	43 Added 172.0%	68 $32.9 Million
Q4 2019 Nov 09, 2023	SELL	$274.13 - $376.51 $822 - $1,129	-3 Reduced 10.71%	25 $9.39 Million
Q3 2019 Nov 09, 2023	BUY	$273.46 - $318.39 $6,836 - $7,959	25 Added 833.33%	28 $7.77 Million
Q3 2017 Nov 09, 2023	BUY	$431.38 - $504.0 $1,294 - $1,512	3	3 $1.34 Million

1,516

82.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

Stay updated on Brewin Dolphin LTD with notifications on news.